PolyPeptide Group AG Cash Flow Reinvestment Rate
PolyPeptide Group AG cash flow reinvestment rate. PolyPeptide Group AG (PPGN) has a Cash Flow Reinvestment Rate of 0.98x as of June 2025, reinvesting CHF48.68 Million (capex CHF48.68 Million ) from operating cash flow of CHF49.66 Million. See financial flexibility index of PolyPeptide Group AG to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of PolyPeptide Group AG (2018–2024)
Cash flow reinvestment rate of PolyPeptide Group AG from 2018 to 2024. Historical reinvestment intensity for PolyPeptide Group AG across 7 annual periods. Explore PPGN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
PolyPeptide Group AG Cash Flow Reinvestment Rate by Year (2018–2024)
PolyPeptide Group AG cash flow reinvestment rate by year from 2018 to 2024. Year-by-year capital reinvestment analysis for PolyPeptide Group AG. For the full cash flow conversion analysis, see PPGN cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.99x | CHF177.99 Million | CHF89.40 Million | CHF86.97 Million | ▼ -37.5% |
| 2023 | 3.19x | CHF116.25 Million | CHF36.48 Million | CHF56.73 Million | ▼ -88.9% |
| 2022 | 28.79x | CHF157.20 Million | CHF5.46 Million | CHF78.76 Million | ▲ +1939.4% |
| 2021 | 1.41x | CHF80.97 Million | CHF57.35 Million | CHF77.71 Million | ▲ +70.9% |
| 2020 | 0.83x | CHF40.88 Million | CHF49.48 Million | CHF40.62 Million | ▲ +102.3% |
| 2019 | 0.41x | CHF22.70 Million | CHF55.60 Million | CHF19.70 Million | ▼ -49.6% |
| 2018 | 0.81x | CHF18.59 Million | CHF22.94 Million | CHF18.30 Million | — |